Angel Porgador, PhD
Angel Porgador, PhD, Ben-Gurion University of the Negev, is the recipient of an ICRF Acceleration Grant. Determining how a patient will react to immunotherapy treatment is very challenging. Professor Porgador will use a new technology that he and a colleague developed, to explore its usefulness for predicting the response to checkpoint blockers (treatments that help the body recognize and attack cancer cells) in lung, kidney, and head and neck cancers.
